EYECRYL PLUS

Monofocal Hydrophilic Acrylic Foldable Intraocular Lens

Eyecryl hydrophilic acrylic IOLs are intended to be implanted into the capsular bag in the posterior chamber of the eye for the visual correction of aphakia secondary to the removal of the crystalline lens in adult patients with cataracts.

eIFU
Publication
Contact

FEATURES

Enhanced Visual Outcomes: The advanced design features of Eyecryl Plus, including its 360° square edge and 5° angulation, contribute to improved visual outcomes post-cataract surgery. By minimizing factors such as posterior capsule opacification and lens misalignment, the lens helps optimize visual acuity and quality for patients, enhancing their overall visual experience.
UV Blocking Material: Eyecryl Plus is crafted from a UV-blocking material, providing additional protection to the eye against harmful ultraviolet radiation. This feature helps mitigate the risk of UV-induced ocular damage and promoting long-term ocular health, reducing the likelihood of associated complications.
Biocompatibility and Safety: Eyecryl Plus is crafted from medical implantable grade hydrophilic acrylic material, ensuring excellent biocompatibility and safety within the ocular environment. This material is well-tolerated by ocular tissues, minimizing the risk of adverse reactions or inflammatory responses post-implantation. Eyecryl Plus undergoes rigorous quality control measures and is packaged in a sterile environment, further enhancing its safety profile.

360 ° square edge
5 ° angulation ensures better contact with posterior capsule
UV blocking Material
Medical implantable grade hydrophilic material
Packed in medical grade blister pack

INGREDIENTS

Eyecryl Plus, a monofocal hydrophilic acrylic foldable intraocular lens, is meticulously crafted from a specialized hydrophilic acrylic material. Eyecryl Plus material meets the highest standards for medical implantation, ensuring optimal biocompatibility and safety within the delicate ocular environment. Formulated to provide exceptional optical clarity and stability, Eyecryl Plus offers patients reliable visual correction following cataract surgery.

OPERATIONS

Eyecryl Plus is primarily utilized in cataract surgery procedures to address aphakia, a condition characterized by the absence of the crystalline lens following cataract extraction. The lens is implanted into the capsular bag in the posterior chamber of the eye, replacing the natural lens and restoring visual acuity. Cataract surgery is one of the most common surgical procedures performed worldwide, making Eyecryl Plus a crucial component in the management of cataract-related visual impairment.

ADVANTAGES

Ease of Implantation: The foldable and injectable nature of Eyecryl Plus facilitates ease of implantation during cataract surgery procedures. Its flexible design allows for smooth insertion through small incisions, minimizing surgical trauma and promoting faster recovery for patients. Eyecryl Plus’s compatibility with existing surgical techniques makes it a convenient and versatile option for ophthalmic surgeons.
Stable and Predictable Refractive Outcomes: Eyecryl Plus delivers stable and predictable refractive outcomes, allowing surgeons to achieve precise emmetropia or targeted refractive corrections post-surgery. This enhances patient satisfaction by minimizing the need for glasses or contact lenses to achieve optimal visual acuity.
Enhanced Patient Comfort: The biocompatible materials and advanced design features of Eyecryl Plus contribute to enhanced patient comfort throughout the postoperative period. Patients experience minimal discomfort, reduced inflammation, and faster visual rehabilitation, allowing them to resume normal activities sooner after surgery.

TECHNICAL SPECIFICATIONS

MODEL600
MATERIALHydrophilic Acrylic CQ UV
OPTIC TYPESingle Piece, 360° Square Edge
OPTIC SIZE6.00 mm
OVERALL SIZE12.50 mm
ANGULATION
ACD4.96
REFRACTIVE INDEX1.462
RECOMMENDED ULTRASOUND A-CONSTANT118.00
RECOMMENDED OPTICAL A-CONSTANTSSRK – T : 118.40
SRK – II : 118.50
HOLLADAY 1 SF : 1.42
HOLLADAY 2 SF: 1.45
HOFFER – Q ACD : 5.19
HAIGIS – a0:0.940, a1:0.400, a2:0.100
Barrett : 1.57
Hill-RBF : 118.30
Olsen ACD : 4.20
DIOPTER RANGE-10.0 to +30.0 D ( with 0.5 D steps from +1.0D to +30.0D )
IMPLANTATION SITECapsular Bag
STERILIZATIONSteam
SHELF LIFE4 year from date of manufacture

SURGERY VIDEO

ACCESS TO INNOVATION
Contact us
Categories
Company
Media
Follow Us

© Copyright Biotech /Terms Of Use - Privacy Policy

Version 2_CT_1212222